Novavax Soars As Its COVID-19 Vaccine Is Found 90% Effective, To Seek FDA OK

Investing.com2021-06-14

Investing.com -- Novavax (NASDAQ:NVAX) shares rose more than 10% in Monday’s premarket trading after the company said a phase-three trial had found its two-dose COVID-19 vaccine to be 90.4% effective....

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • Harris8900
    2021-06-24
    Harris8900
    Good news
  • woonws
    2021-06-15
    woonws
    Good to have another vaccine option!
  • 13cd0426
    2021-06-15
    13cd0426
    Yo
  • Qlee10
    2021-06-15
    Qlee10
    cool! 
  • Whyeloon
    2021-06-15
    Whyeloon
    About time…i have been nursing losses on this stock for a while now..onwards and upwards, please…💰💰💰
  • BlessedCyrus
    2021-06-14
    BlessedCyrus
    Doubt they will get EUA since most American are already vaccinated with MRNA from BioNTech and Moderna? For normal approval from FDA, it should take up till 2022? 
发表看法
34